Drug detoxification | Opioid Substitution Treatment (OST) | Rusan Pharmaceutical

	Highlights
1994 Rusan Pharma Ltd. incorporated by chairman Dr. Navin Saxena 1996 Inauguration of Research & Development Centre at Rusan's Head Quarter in Mumbai 1997 Rusan Pharma Ltd bags an award for Excellence in Productivity, Quality and Innovation. Chairman, Dr. Navin Saxena receives "Udyog Ratna" Award from Government of India. 1999 Bulk Drug Manufacturing unit acquired in Ankleshwar, Gujarat 2000 Rusan Pharma Ltd acquires Novartis factory in Kandla Special Economic Zone, Gandhidham, Gujarat. Rusan Pharma Ltd receives "Chemexcil Award" for Outstanding Export Performance. 2001 Rusan Pharma Ltd Bags Excellence Award from CHEMEXCIL. 2002 Rusan Pharma Ltd starts the concept of OST in Ukraine in collaboration with UNODC Inaguration of Rusan Pharma's Kandla formulation facility WHO-GMP accreditation for formulation manufacturing facility in Kandla, received. Research Centre at Mumbai approved by Ministry of Science and Technology, Government of India. GMP accreditation for Bulk Drug manufacturing facility at Ankleshwar received. 2003 UK- MHRA Accreditation for formulation manufacturing facility at Kandla received. South Africa - MCC Accreditation for formulation manufacturing facility at Kandla received. Zimbabwe - MCAZ accreditation for formulation manufacturing facility at Kandla received. COS for Buprenorphine Hydrochloride received from EDQM. Rusan makes entry into regulated market of UK and South Africa through the supply of Generics. 2004 Sudan - MOH Accreditation for formulation manufacturing facility at Kandla received. 2005 Rusan Pharma Ltd Exports more than 100 formulation to UK,South Africa, CIS, Asia. UAE - MOH Accreditation for formulation manufacturing facility at Kandla received. 2006 Uganda-NDA Accreditation for formulation manufacturing facility at Kandla received. API Plant capacity increased 5 folds, for various molecules. Land acquired for second formulation facility at Dehradun Uttarakhand. 2007 Renewal of UK- MHRA GMP for Kandla facility. Rusan bags South Africa TB Tender for four drug and two drug combination. 2008 UK - MHRA-GMP Approval for API plant in Ankleshwar, Gujarat. COS for Fentanyl base received from EDQM. COS for Buprunorphine base received from EDQM WHO-GMP accreditation for formulation manufacturing facility in Dehradun, received. 2009 Inauguration of Dehradun Formulation facility. 2010 COS for Naltrexone Hydrochloride received from EDQM PausePlay \| Up \| Down scroll

Welcome to Rusan

High-quality public health is vital for a functioning society and a country’s economic growth. We, at Rusan Pharma Ltd, understand this and are committed to providing improved solutions. Rusan Pharma Ltd. is a technology driven pharmaceutical company with interests in research and development, manufacturing and marketing of formulations, APIs and their intermediates. We specialize in opioid de-addiction, critical and acute pain management, anti-tuberculosis and psychotropic drugs.

At Rusan, we are guided by professional leadership and experience, commitment towards quality and delivery and a good understanding of business complexities. We work with exemplary business practices and work ethics, and implement new ideas efficiently and effectively. Rusan also believe that success is often achieved through close collaboration with partners who share a common vision and possess complementary strengths. With the ever changing industry trends we are ready to take on fresh challenges by embracing original technologies, novel drug delivery systems, and biocatalysts. That is why we are confident that with strong leadership, motivated partners and new technologies we can provide a better quality service to our customers.

	Our Niche
Untitled Document

	What's New

Our Product Range

Home | About us | Products | Facilities | Doctor’s Section | Career | Feedback | Contact us | Sitemap XML | Sitemap | Google Plus
Copyrights © 2014 , Rusan Pharma. All rights reserved
Website Design & Maintain by : Creative Brand Ripples Pvt. Ltd.